April 4, 1989
Dr. Philip Needleman, Monsanto Corporation, Research and Development
Biochemical Pharmacology of Atriopeptin and Related Peptides

April 20, 1990
Dr. Eric Shooter, Stanford University
Nerve Growth Factor - From Molecule to Memory

May 9, 1991
Dr. A. M. Goldberg, Johns Hopkins University
Animal Use and Alternative

May 15, 1992
Dr. Keith Killam, University of California - Davis, School of Medicine
Through a Looking Glass -- Pharmacologically

May 7, 1993
Dr. Ray Fuller, Lilly Research Laboratories
Pharmacology Careers in the Pharmaceutical Industry

June 10, 1994
Dr. Irwin Fridovich, Duke University Medical Center
What is the Matter with Oxygen?

June 16, 1995
Dr. Louis Ignarro, University of California - Los Angeles, Medical Center
The Physiologic Significance of the Nitric Oxide-Cyclic GMP Signal Transduction Pathway in Mammalian Cells

May 3, 1996
Dr. Palmer Taylor, University of California - San Diego, School of Medicine
A Tale of Divergence in Specificity and Gene Expression at Two Cholinergic Sites

June 3, 1997
Dr. Philip Needleman, Searle Research and Development
The Road to a Better, No, a Much Better Aspirin

June 10, 1998
Dr. Michael Williams, Abbott Laboratories
The Analgesic Frog:  Serendipity in the Drug Discovery Process

June 8, 1999
Dr. Eugene Sun, Abbott Laboratories
ABT-378 and the Continuing Therapeutic Challenges of HIV

June 1, 2000
Dr. Malcolm Cohen, NASA-Ames Research Center
"Astrobiology and Space Travel: The Big Picture"
and
Dr. Janice Voss, Astronaut, NASA-Johnson Space Center
"Another Perspective of Research in Space"

May 31, 2001
Dr. Stephen Morse, Center for Disease Control (CDC)
"Bioterrorism: Are We Prepared?"

June 10, 2002
Dr. Neil Granger, LSU Health Science Center, Shreveport
"Adhesion of Blood Cells to Microvascular Endothelium:
Mechanisms and Targets for Therapeutic Intervention"

May 8, 2003
Dr. Hal E. Broxmeyer, The Walther Oncology Center,
Indiana University School of Medicine
The Biology and Therapeutics of Hematopoietic Stem Cells
from Cord Blood and mobilized Peripheral Blood"

June 3, 2004
David Holtzman, M.D., Ph.D., Department of Neurology
Washington University, St. Louis
“Potential Role of Amyloid-Beta Binding Molecules in the Pathogenesis,
Diagnosis and Treatment of Alzheimer’s Disease”

June 17, 2005
Rene Hen, Ph.D., Center for Neurobiology and Behavior
Columbia University
"The Requirement of Hippocampal Neurogenesis for the
Behavioral and Physiologic Effects of Antidepressants"

June 9, 2006
Michael B. Sporn, M.D.
 Dartmouth Medical Center
“New synthetic triterpenoids and rexinoids: multifunctional agents with many
potential clinical applications, both for prevention & treatment of disease.”

Friday, June 13, 2008

Preliminary Program

Neal Benowitz,
University of California San Francisco

Chicago Cultural Center, 78 East Washington St., Chicago